CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma

Published:2019-06-27 Issue:4 Volume:13 Page:440-453
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Liao Xia,Bu Yang,Jiang Shanshan,Chang Fan,Jia Fengan,Xiao Xuelian,Song Ge,Zhang Mei,Ning Pengbo,Jia Qingan

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Postdoctoral Research Foundation of China

Natural Science Foundation of Ningxia Province

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-019-09960-5.pdf

Reference42 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424

2. Page AJ, Cosgrove DC, Philosophe B, Pawlik TM. Hepatocellular carcinoma diagnosis, management, and prognosis. Surg Oncol Clin N Am 2014;23:289

3. Bu Y, Jia QA, Ren ZG, Zhang JB, Jiang XM, Liang L, et al. Maintenance of stemness in oxaliplatin-resistant hepatocellular carcinoma is associated with increased autocrine of IGF1. PLoS One 2014;9:e89686

4. Jia Q, Dong Q, Qin L. CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma? Oncotarget 2016;7(2):1203–1214

5. Brigstock DR, Goldschmeding R, Katsube K, Lam SCT, Lau LF, Lyons K, et al. Proposal for a unified CCN nomenclature. J Clin Pathol Mol Pathol 2003;56:127–128

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ALOX12B and PRMT5 inhibit stemness and EMT in esophageal squamous cell carcinoma by promoting decorin expression;2024-08-29

2. Advances in hepatocellular carcinoma drug resistance models;Frontiers in Medicine;2024-07-31

3. Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach;BMC Complementary Medicine and Therapies;2023-10-05

4. Hepatocyte-Specific Smad4 Deficiency Alleviates Liver Fibrosis via the p38/p65 Pathway;International Journal of Molecular Sciences;2022-10-02

5. E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma;Translational Cancer Research;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3